Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Marat V. Ezhov"'
Autor:
Svetlana N. Nasonova, Aleksei N. Meshkov, Igor V. Zhirov, Yulia F. Osmolovskaya, Anastasiia A. Shoshina, Alan V. Gagloev, Irina H. Dzhumaniiazova, Elena A. Zelenova, Veronika V. Erema, Mariia S. Gusakova, Mikhail V. Ivanov, Mikhail V. Terekhov, Daria A. Kashtanova, Alexsandra I. Nekrasova, Sergey I. Mitrofanov, Andrey S. Shingaliev, Vladimir S. Yudin, Anton A. Keskinov, Nataliya V. Gomyranova, Uliana V. Chubykina, Marat V. Ezhov, Sergey N. Tereshchenko, Sergey M. Yudin, Sergey A. Boytsov
Publikováno v:
Терапевтический архив, Vol 96, Iss 09, Pp 901-908 (2024)
Dilated cardiomyopathy (DCM) is a leading cause of heart failure, sudden cardiac death, and heart transplantation in young patients. The causes of DCM are varied and include genetic factors and metabolic, infectious, toxic and others factors. Today i
Externí odkaz:
https://doaj.org/article/a8708c4436734c58bb4e28c604e1b7c4
Autor:
Kristina Yu. Zherebchikova, Dmitry S. Bubnov, Alexandra S. Ermolaeva, Madina O. Soltakhanova, Yulia P. Sych, Marat V. Ezhov, Valentin V. Fadeev
Publikováno v:
Consilium Medicum, Vol 26, Iss 1, Pp 7-11 (2024)
Atrial fibrillation is the most common heart rhythm disorder in patients with chronic heart failure. One of the most effective antiarrhythmic drugs for the treatment and prevention of a wide range of supraventricular and ventricular tachyarrhythmia i
Externí odkaz:
https://doaj.org/article/07941297c2074e4188187a100fc2818a
Autor:
Inga V. Anisimova, Marina B. Albegova, Madlena E. Bagaeva, Galina V. Baidakova, Aleksandr A. Baranov, Nato D. Vashakmadze, Elena A. Vishneva, Olga S. Gundobina, Anna V. Degtiareva, Marat V. Ezhov, Maria S. Zharkova, Nataliia V. Zhurkova, Ekaterina Yu. Zaharova, Vladimir T. Ivashkin, Elena A. Kamenets, Sergey I. Kutzev, Alla E. Lavrova, Irina A. Matinian, Svetlana V. Mikhailova, Leyla S. Namazova-Baranova, Irina E. Pashkova, Elena E. Petriaykina, Tatiana M. Pervunina, Nataliia L. Pechatnikova, Nelia S. Pogosian, Svetlana A. Repina, Lilia R. Selimzianova, Tamara A. Skvortsova, Tatiana V. Strokova, Dmitriy M. Subbotin, Andrey N. Surkov, Elena L. Tumanova, Ekaterina G. Tzimbalova
Publikováno v:
Педиатрическая фармакология, Vol 20, Iss 4, Pp 337-354 (2023)
Lysosomal acid lipase deficiency is s a rare hereditary enzymopathy. The article presents epidemiological data and features of etiopathogenesis of two phenotypic forms of lysosomal acid lipase deficiency — Wolman disease and cholesterol ester stora
Externí odkaz:
https://doaj.org/article/bbadc6c645734812b65cf6da590af630
Autor:
Marat V. Ezhov, Ekaterina V. Gushanskaya, Maxim L. Maximov, Yulia M. Yufereva, Alexander V. Rozanov
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 1, Pp 44-48 (2023)
Cardiovascular diseases are the leading cause of mortality in the world. Effective treatment and prevention of cardiovascular disorders is impossible without the risk factor correction. Smoking remains the most important modifiable risk factor of car
Externí odkaz:
https://doaj.org/article/39ddcb78d27146399195a250f58af834
Autor:
Irina S. Zakharova, Alexander I. Shevchenko, Mhd Amin Arssan, Aleksei A. Sleptcov, Maria S. Nazarenko, Aleksei A. Zarubin, Nina V. Zheltysheva, Vlada A. Shevchenko, Narek A. Tmoyan, Shoraan B. Saaya, Marat V. Ezhov, Valery V. Kukharchuk, Yelena V. Parfyonova, Suren M. Zakian
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 689 (2024)
Defects in the low-density lipoprotein receptor (LDLR) are associated with familial hypercholesterolemia (FH), manifested by atherosclerosis and cardiovascular disease. LDLR deficiency in hepatocytes leads to elevated blood cholesterol levels, which
Externí odkaz:
https://doaj.org/article/1a367c718be94a42babd8f91bc18a80c
Autor:
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Margus Viigimaa, Pedro Valdivielso, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106679- (2023)
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25% of the general adult population, 15% of children, and even > 50% of individuals who have type 2 diabetes mellitus. It is a major cause of liver-related morbidit
Externí odkaz:
https://doaj.org/article/899e9c48cd3d4c8196a16bde19882118
Autor:
Elena A. Klesareva, Olga I. Afanasieva, Ekaterina E. Sherstyuk, Narek A. Tmoyan, Oksana A. Razova, Aleksandra V. Tyurina, Marina I. Afanasieva, Marat V. Ezhov, Sergei N. Pokrovsky
Publikováno v:
Терапевтический архив, Vol 94, Iss 4, Pp 479-484 (2022)
Background. Hyperlipoproteinemia (a) is an independent and cause risk factor for atherosclerotic cardiovascular diseases (ASCVD). The correlation between lipoprotein (a) Lp(a) and inflammation in the vessel wall was actively studied during the past f
Externí odkaz:
https://doaj.org/article/891af57acb694a51b9d879a179699733
Autor:
Marat V. Ezhov, Igor V. Sergienko, Sergey M. Kryzhanovskiy, Kirill S. Manko, Elena V. Timoshina
Publikováno v:
Diseases, Vol 11, Iss 4, p 168 (2023)
Background: The objective of this study was to conduct a comparative evaluation of the effectiveness of ezetimibe in combination with statins or statin monotherapy in patients with hypercholesterolemia in a real-world setting. Methods: It was a retro
Externí odkaz:
https://doaj.org/article/c4375ec0abe8410bbf5b2f4ac5ff156c
Autor:
Marat V. Ezhov, Gregory P. Arutyunov
Publikováno v:
Diseases, Vol 11, Iss 4, p 140 (2023)
Background: Multiple trials have demonstrated the efficacy of fenofibrate for the management of dyslipidemia. Real-world evidence may provide important insights into the effectiveness and safety of fenofibrate in patients with metabolic syndrome and
Externí odkaz:
https://doaj.org/article/8a8e8853006240d28851a330d05edeba
Autor:
Olga I. Afanasieva, Alexandra V. Tyurina, Marat V. Ezhov, Oxana A. Razova, Elena A. Klesareva, Sergei N. Pokrovsky
Publikováno v:
Diseases, Vol 11, Iss 4, p 145 (2023)
Background. Lipoprotein(a) (Lp(a)) is a genetic risk factor of atherosclerotic cardiovascular diseases (ASCVDs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is related to vascular inflammation and detected in atherosclerotic plaques. A temp
Externí odkaz:
https://doaj.org/article/a8c3b2d17c1a45dd885c87ce0a748256